Sterile syringe access and disposal among injection drug users newly enrolled in methadone maintenance treatment: A cross-sectional survey

Harm Reduction Journal

Volumn 3, Issue , 2006, Pages

  McNeely, Jennifer ^a   Arnsten, Julia H ^b   Gourevitch, Marc N ^c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHADONE;

ADULT; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DRUG DEPENDENCE; FEMALE; HARM REDUCTION; HEALTH CARE DELIVERY; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INSTRUMENT STERILIZATION; INTERVIEW; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; PRESCRIPTION; PREVALENCE; SAFETY; SHARPS DISPOSAL; SYRINGE; UNITED STATES; WASTE DISPOSAL;

EID: 33644959317     PISSN: 14777517     EISSN: 14777517     Source Type: Journal    
DOI: 10.1186/1477-7517-3-8     Document Type: Article

References (32)

1. U.S. Department of Health and Human Services, Public Health Service: HIV prevention bulletin: Medical advice for persons who inject illicit drugs. [http://www.cdc.gov/idu/pubs/hiv prev.htm]. May 9, 1997, Accessed March 9, 2004
2. Centers for Disease Control and Prevention: Viral Hepatitis and Injection Drug Users. 2002 [http://www.cdc.gov/idu/hepatitis/viral_hep_drug_use.htm]. Accessed May 31, 2004.
3. Normand J, Vlahov D, Moses LE, (Eds): Preventing HIV transmission: The role of sterile needles and bleach Washington, DC: National Academy Press; 1995.
4. Lurie P, Jones TS, Foley J: A sterile syringe for every drug user injection: How many injections take place annually, and how might pharmacists contribute to syringe distribution? Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1998, 18(Suppl 1):S45-S51.
5. Gleghorn AA, Wright-De Aguero L, Flynn C: Feasibility of one-time use of sterile syringes: A study of active injection drug users in seven United States metropolitan areas. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1998, 18(Suppl 1):S30-S36.
6. Gleghorn AA, Jones TS, Doherty MC, Celentano DD, Vlahov D: Acquisition and use of needles and syringes in Baltimore, Maryland. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology 1995, 10(1):97-103.
7. National Institutes of Health: Consensus Development Statement: Interventions to prevent HIV risk behaviors, February 11-13, 1997 [http://consensus.nih.gov/cons/104/104 statement.htm]. Accessed March 9, 2004
8. Des Jarlais DC, Friedman SR, et al.: Continuity and change within an HIV epidemic: Injecting drug users in New York City, 1984 through 1992. JAMA 1994, 271:121-127.
9. Center for Urban Epidemiologic Studies, New York Academy of Medicine: New York State Expanded Syringe Access Demonstration Project (ESAP): Evaluation Report to the Governor and State Legislature. New York 2003.
10. Novick DM, Joseph H, et al.: Absence of antibody to Human Immunodeficiency Virus in long-term, socially rehabilitated methadone maintenance patients. Archives of Internal Medicine 1990, 150:97-99.
11. Metzger D, Woody G, McLellan T, et al.: Human immunodeficiency virus seroconversion among intravenous drug users in- and out-treatment: an 18-month prospective follow-up. Journal of Acquired Immune Deficiency Syndrome 1993, 6:1049-1056.
12. Ball JC, Lange WR, Myers CP, Friedman SR: Reducing the risk of AIDS through methadone maintenance treatment. Journal of Health and Social Behavior 1998, 29:214-226.
13. Ball JC, Ross A: The Effectiveness of Methadone Maintenance Treatment New York: Springer-Verlag, 1991.
14. Schoenbaum EE, Hartel DM, Gourevitch MN: Needle exchange use among a cohort of injecting drug users. AIDS 1996, 10:1729-1734.
15. Hartel DM, Schoenbaum EE, Selwyn PA, Friedland GH, Klein RS, Drucker E: Patterns of heroin, cocaine and speedball injection among Bronx (USA) methadone maintenance patients: 1978-1988. Addiction Research 1997, 8:394-404.
16. Forman RF, Bovasso G, Woody G: Staff beliefs about addiction treatment. Journal of Substance Abuse Treatment 2001, 21(1):1-9.
17. Caplehorn JR, Hartel DM, Irwig L: Measuring and comparing the attitudes and beliefs of staff working in New York methadone maintenance clinics. Substance Use and Misuse 1997, 32(4):399-413.
18. Des Jarlais DC, Perlis T, Friedman SR, et al.: Behavioral risk reduction in a declining HIV epidemic: injection drug users in New York City, 1990-1997. American Journal of Public Health 2000, 90:1112-1116.
19. Centers for Disease Control and Prevention: Update: syringe exchange programs - United States, 2002. Morbidity and Mortality Weekly Report (MMWR) 54(27):673-676. July 15, 2005
20. Khoshnood K, Blankenship KM, Pollack HA, Roan CT, Altice FL: Syringe source, use, and discard among injection-drug users in New Haven, Connecticut. AIDS Public Policy Journal 2000, 15(3-4): 88-94.
21. Heimer R, Khoshnood K, Bigg D, Guydish J, Junge B: Syringe use and reuse: effects of syringe exchange programs in four cities. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1998, 18(Suppl 1):S37-44.
22. Bluthenthal RN, Malik MR, Grau LE, Singer M, Marshall P, Heimer R: Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities. Addiction 2004, 99(9):1136-1146.
23. Hagan H, Thiede H: Changes in injection risk behavior associated with participation in the Seattle needle-exchange program. Journal of Urban Health 2000, 77(3):369-382.
24. Rich JD, Dickinson BP, Liu KL, Case P, Jesdale B, Ingegneri RM, Nolan PA: Strict syringe laws in Rhode Island are associated with high rates of reusing syringes and HIV risks among injection drug users. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1998, 18(Suppl 1):S140-141.
25. Vlahov D, Junge B, Brookmeyer R, Cohn S, Riley E, Armenian H, Beilenson P: Reductions in high-risk drug use behaviors among participants in the Baltimore needle exchange program. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1997, 16(5):400-406.
26. Longshore D, Annon J, Anglin MD: Long-term trends in self-reported HIV risk behavior: injection drug users in Los Angeles, 1987 through 1995. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1998, 18(1):64-72.
27. Finkelstein R, Tiger R, Greenwald R, Mukherjee R: Pharmacy syringe sale practices during the first year of expanded syringe availability in New York City (2001-2002). Journal of the American Pharmaceutical Association 2002, 42(6, Suppl 2):S83-87.
28. Springer KW, Sterk CE, Jones TS, Friedman L: Syringe disposal options for injection drug users: A community-based perspective. Substance Use and Misuse 1999, 34:1917-1934.
29. Burris S, Welsh J, Ng M, Li M, Ditzler A: State syringe and drug possession laws potentially influencing safe syringe disposal by injection drug users. Journal of the American Pharmaceutical Association 2002, 42(6, Suppl 2):S94-S98.
30. Frank B: An overview of heroin trends in New York City: Past, present and future. Mount Sinai Journal of Medicine 2000, 67:340-346.
31. Latkin CA, Vlahov D: Socially desirable response tendency as a correlate of accuracy of self-reported HIV serostatus for HIV seropositive injection drug users. Addiction 1998, 93(8):1191-1197.
32. De Irala J, Bigelow C, McCusker J, Hindin R, Zheng L: Reliability of self-reported human immunodeficiency virus risk behaviors in a residential drug treatment population. American Journal of Epidemiology 1996, 143(7):725-732.